Barilli, A.; Visigalli, R.; Recchia Luciani, G.; Crescini, E.; Dall’Asta, V.; Rotoli, B.M.
Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs. Int. J. Mol. Sci. 2025, 26, 8672.
https://doi.org/10.3390/ijms26178672
AMA Style
Barilli A, Visigalli R, Recchia Luciani G, Crescini E, Dall’Asta V, Rotoli BM.
Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs. International Journal of Molecular Sciences. 2025; 26(17):8672.
https://doi.org/10.3390/ijms26178672
Chicago/Turabian Style
Barilli, Amelia, Rossana Visigalli, Giulia Recchia Luciani, Eleonora Crescini, Valeria Dall’Asta, and Bianca Maria Rotoli.
2025. "Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs" International Journal of Molecular Sciences 26, no. 17: 8672.
https://doi.org/10.3390/ijms26178672
APA Style
Barilli, A., Visigalli, R., Recchia Luciani, G., Crescini, E., Dall’Asta, V., & Rotoli, B. M.
(2025). Baricitinib and Infliximab Mitigate the Endothelial-to-Mesenchymal Transition (EndMT) Induced by Cytokines in HUVECs. International Journal of Molecular Sciences, 26(17), 8672.
https://doi.org/10.3390/ijms26178672